Overview

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

Status:
Not yet recruiting
Trial end date:
2023-08-26
Target enrollment:
Participant gender:
Summary
A clinical trial to compare the pharmacokinetic and safety of CKD-828 20/1.25mg
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical